Multiple Myeloma Research Foundation (MMRF) and Indapta Therapeutics Announce Investment to Advance Clinical Development of Natural Killer Cell Therapy
October 28, 2020
View
MMRF Venture Philanthropy Fund Invests in Cullinan MICA to Bring First-In-Class Immuno-Oncology Antibody into the Clinic
June 11, 2020
Building to the Pinnacle of Precision Medicine: Translating the MMRF CoMMpass Study into Actionable Insights and Clinical Trials
May 22, 2020
Meet Mandy and Caroline Freer: 2022 Bank of America Chicago Marathon Finishers
January 7, 2020
Multiple Myeloma Research Foundation (MMRF) Venture Philanthropy Fund Invests in NexImmune to Advance Novel Immunotherapy Candidate Into Clinical Trials
April 29, 2019
Knowledge is power. Sign up today and we’ll help you stay informed.
sign up
We value your privacy.
